LPL Financial’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

LPL Financial’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,244	Closed	-$444K	–	3312
2015 Q3	$444K	Buy	10,244 +553	+6%	+$23.3K	﹤0.01%	1890
2015 Q2	$373K	Buy	9,691 +266	+3%	+$11.2K	﹤0.01%	2134
2015 Q1	$360K	Buy	9,425 +501	+6%	+$19.3K	﹤0.01%	2106
2014 Q4	$300K	Buy	8,924 +482	+6%	+$17K	﹤0.01%	2162
2014 Q3	$295K	Buy	+8,442	New	+$289K	﹤0.01%	2186

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

LPL Financial's WX Position: Q4 2015 in Review

LPL Financial sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 10,244 shares — an estimated $444K sold.

LPL Financial first reported a position in WX in Q3 2014 and held it in 5 quarters. The position peaked at $444K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

LPL Financial reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
LPL Financial sold 10,244 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $444K.
LPL Financial first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2014 and held it in 5 quarters.
LPL Financial's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $444K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on LPL Financial's 13F filing for Q4 2015, filed 12 Feb 2016.